Arkolith/Insider Trading/KZR/Form 4

Garner Elizabeth

DirectorKezar Life Sciences, Inc. (KZR) · full profile →Form 4 · filed May 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
0 non-derivative · 7 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2026Disposed to issuer(D)4K—$00
May 11, 2026Disposed to issuer(D)5K—$00
May 11, 2026Disposed to issuer(D)5K—$00
May 11, 2026Disposed to issuer(D)2K—$00
May 11, 2026Disposed to issuer(D)889—$00
May 11, 2026Disposed to issuer(D)3K—$00
May 11, 2026Disposed to issuer(D)3K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001608578-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML